MNKD vs QDEL: fair value comparison
MannKind Corporation and QuidelOrtho Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, MNKD currently sits closer to the top of our discount ranking. MNKD carries the stronger quality grade.
| MNKD | QDEL | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $3.98 | $13.75 |
| 12-month range | $2.54–$6.01 | $12.64–$31.25 |
| Sector rank | #24 of 113 Healthcare | #28 of 113 Healthcare |
| Quality grade | C | F |
| Leverage | Low | High |
| Margin trend | Stable | Contracting |
| Revenue growth | High | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: MNKD fair value analysis · QDEL fair value analysis